|
Market Closed -
Nasdaq
16:00:00 2026-11-11 EST
|
5-day change | 1st Jan Change | ||
| 4.640 USD | -0.85% |
|
+14.00% | -49.86% |
| 10-21 | Lexaria Bioscience Corp. Reaches Full Enrollment and Continues Dosing on Schedule with Human Pilot Study #7 | CI |
| 10-15 | Lexaria Bioscience Corp. Announces Results from Animal Study Glp-1-A26-1 | CI |
| Market Cap | 9.86M 8.89M 8.21M 7.42M 14.04M 925M 14.39M 98.38M 39.21M 495M 37M 36.21M 1.58B | P/E 2026 * |
-1.16x | P/E 2027 * | -1.01x |
|---|---|---|---|---|---|
| Enterprise Value | 9.86M 8.89M 8.21M 7.42M 14.04M 925M 14.39M 98.38M 39.21M 495M 37M 36.21M 1.58B | EV / Sales 2026 * |
493x | EV / Sales 2027 * | 7.03x |
| Free-Float |
97.4% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| LEXX | Delayed | |
CBOE
| LEXX | Real-time |
| 1 day | -0.85% | ||
| 1 week | +14.00% | ||
| Current month | +32.95% | ||
| 1 month | +41.90% | ||
| 3 months | -19.86% | ||
| 6 months | -48.85% | ||
| Current year | -49.86% |
| 1 week | 3.87 |  | 4.79 |
| 1 month | 2.43 | | 4.79 |
| Current year | 2.43 | | 15.9 |
| 1 year | 2.43 | | 21.6 |
| 3 years | 2.43 | | 102.75 |
| 5 years | 2.43 | | 102.75 |
| 10 years | 2.43 | | 1,143 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 2024-08-30 | |
Michael Shankman
DFI | Director of Finance/CFO | 66 | 2024-09-30 |
John Docherty
PSD | President | 55 | 2015-04-14 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 65 | 2006-10-25 | |
Nicholas Baxter
BRD | Director/Board Member | 72 | 2011-07-07 |
John Docherty
BRD | Director/Board Member | 55 | 2016-04-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/17/26 | Other | Chairman | 100,000 | 0.4018% | ||
| 7/29/25 | Buy | General Counsel | 750 | 0.0043% | ||
| 7/29/25 | Other | Chairperson | 5,376 | 0.0306% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.85% | +14.00% | -72.38% | -76.57% | 9.86M | |
| +0.35% | +1.36% | +45.38% | +134.58% | 1,276B | |
| -0.13% | +1.48% | +44.67% | +89.94% | 676B | |
| +0.37% | +0.05% | +31.00% | +112.77% | 519B | |
| +0.02% | +2.79% | +44.10% | +69.76% | 388B | |
| -0.59% | -2.11% | +61.83% | +43.63% | 365B | |
| -1.29% | +0.94% | +29.88% | +58.29% | 307B | |
| +0.09% | +0.99% | +5.87% | +37.72% | 287B | |
| +0.62% | -2.17% | +38.31% | +75.53% | 252B | |
| -0.67% | -2.72% | +38.49% | +126.52% | 212B | |
| Average | -0.09% | +3.72% | +26.71% | +67.22% | 428B | |
| Weighted average by Cap. | +0.08% | +2.51% | +40.29% | +95.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 20K 18.03K 16.65K 15.06K 28.48K 1.88M 29.19K 200K 79.55K 1M 75.06K 73.46K 3.2M | 1.4M 1.26M 1.17M 1.06M 2M 132M 2.05M 14M 5.58M 70.47M 5.27M 5.15M 224M |
| Net income | -6.64M -5.98M -5.53M -5M -9.45M -623M -9.69M -66.25M -26.41M -333M -24.92M -24.39M -1.06B | -8.95M -8.06M -7.45M -6.73M -12.74M -839M -13.06M -89.29M -35.59M -449M -33.58M -32.86M -1.43B |
| Net Debt | - | - |
Employees
7
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-11 | US$4.640 | -0.85% | 9,199 |
| 26-11-10 | US$4.680 | +3.08% | 12,163 |
| 26-11-09 | US$4.540 | +0.89% | 17,980 |
| 26-11-06 | US$4.500 | +7.91% | 30,039 |
| 26-11-05 | US$4.170 | +2.46% | 30,035 |
- Stock Market
- Stocks
- LEXX Stock
Select your edition
All financial news and data tailored to specific country editions
